GlassScriptPhysician profile
Paul M Colopy
NPI 1811999550
$958.38
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.58 · 2020: $98.82 · 2021: $205 · 2022: $599 · 2023: $35.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $442.85 | 2022 | |
| Allergan, INC. | $104.71 | 2019-2020 | |
| Lundbeck LLC | $83.77 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $67.23 | 2021 | |
| Biogen, INC. | $47.94 | 2021-2022 | |
| Argenx US, INC. | $35.52 | 2023 | Vyvgart |
| Teva Pharmaceuticals USA, INC. | $34.20 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.26 | 2022 | |
| Livanova USA, INC. | $30.11 | 2021-2022 | |
| Lilly USA, LLC | $27.59 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $18.86 | 2021 | |
| Amgen INC. | $17.74 | 2021 | |
| Abbvie INC. | $14.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Colopy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.